Lilly receives FDA’s breakthrough therapy designation for ovarian cancer drug

Please subscribe to IBJ to decode this article.

emy uv rhecaSl eteg rFUivapregnohvcatni'fdi.oio ninr sAta dkra LDoe iesn ap altrheh ei.oto u ln .lmay.str dau ed inegedroh Ct strn gEontdaianradsiorntoednac cbitar etipt

eewi.iy,h paramonazasl fbt inom,sellneht,Tm aeereovrrmrivlreetldpimaareTiliptnu h dcfieuoa aalrri aostt ae ha ar eorltmbrv c anec -edtgpryn aibs esbieauaivahnnlut uepnon avt erlmrfo iistfbio rx biooru tgtkafp iic ev- ausaeonaidp ti i ieadm tetasgd isdssdttweenaetanb echnIvritepnn a h oeasidcpit

aagnc md fr rpwnmo .uneesrfottvdieveda eaorc D bocFtmoiadnirteelswtteavt siutged uirtetsiseilsnorgaeadbrnpiati dt g as sirrpveaneaee v oirnhalorsyrfl nn hhtoepeish h uieedr ue itpa ihvmTptatima nceekit h ei s gcxdo oolnhbeyg silecieate hnmlpne’i a ieAdr

eed srpai gTydh,dnnasemefl gie rtroeou 1ic oet epnsntpenLsa e rae tnB iraiWuluvarm ensstntcodemdn s na ovfipatsnamedptaabes efooaggonl nanp tutnpttFaercgesoaiw g“Pnosa dh huioadshse, ceedp ota nfersnlrryoman ecyaD-dttraiia .ifcerlo froitiih”knc aoiritediaJtehit a tle ny iiatrnrrgaNatmAnnnihehsnc st,eite b re hent eaVts snlOnui euw i b hsrdl, l

rnrtreesc et- i .insa an eveU-psinusinyonet eltrhtapec dutirtehm emselhtn eu ct iri L dlhuri srowle%i em ertr geueeeeia rO sanddhec t, ob ciencolssftaiani .i dmaaepfm txbasarf ioqlttaetletgra ,a S sc pa anhlwwaipdtypen ctonoiourmnuiodbs0naonso7med nsen c yhchhei ogetl tbatiet

a npmnooaeuei wsrt ercrettiskdlt ttrn ut paaa-mo nueensdg slies sncwe pim ti tetenePcnasristax, airmnyidohich awi.tr shasl infn efnrmhuootnip t

tyrreamtihot-euTlgonnwagBCee rrf ,ou itl atUlsugslYadciu“Peto nehreenrnnet tL , to n ttneaeHeoernl onctldiC c dsPnpromNeter a e nltc,thcn ine rgogie ivaatnCaitenns tOshahnao" a sloio hifratiaemc smeltaar,rhsidnt iie mfl ef oovtnatag srincoss iltao iit. mornwte i npintoatshemtoirianccg accat fytpPome e

d in c vtyaaeie m l es’ssiiernoLhtl puteana dahto rnonirs/tesromh inFho brd y’d eeam afeielritrob. aiw l sieencyc, rcsysf h,AsgTtaaasu a1 dn y a3b dtryo oicLodpesluglat hihnpufDthylPgcskr atPr bet